These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32847581)

  • 1. Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs.
    Mata-Cases M; Mahon J; Mauricio D; Franch-Nadal J; Real J; Hex N
    BMC Health Serv Res; 2020 Aug; 20(1):803. PubMed ID: 32847581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefit.
    Baxter M; Hudson R; Mahon J; Bartlett C; Samyshkin Y; Alexiou D; Hex N
    Diabet Med; 2016 Nov; 33(11):1575-1581. PubMed ID: 26773733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK.
    Bain SC; Bekker Hansen B; Hunt B; Chubb B; Valentine WJ
    J Med Econ; 2020 Jan; 23(1):98-105. PubMed ID: 31311364
    [No Abstract]   [Full Text] [Related]  

  • 4. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study).
    Laiteerapong N; Ham SA; Gao Y; Moffet HH; Liu JY; Huang ES; Karter AJ
    Diabetes Care; 2019 Mar; 42(3):416-426. PubMed ID: 30104301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes.
    Kim K; Unni S; Brixner DI; Thomas SM; Olsen CJ; Sterling KL; Mitchell M; McAdam-Marx C
    Diabetes Obes Metab; 2019 Jul; 21(7):1725-1733. PubMed ID: 30848039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modelling study of the budget impact of improved glycaemic control in adults with Type 1 diabetes in the UK.
    Choudhary P; de Portu S; Delbaere A; Lyon J; Pickup JC
    Diabet Med; 2019 Aug; 36(8):988-994. PubMed ID: 30710449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.
    Wysham CH; Pilon D; Ingham M; Lafeuille MH; Emond B; Kamstra R; Pfeifer M; Lefebvre P
    Endocr Pract; 2018 Mar; 24(3):273-287. PubMed ID: 29547044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving life expectancy and decreasing the incidence of complications associated with type 2 diabetes: a modelling study of HbA1c targets.
    Valentine WJ; Palmer AJ; Nicklasson L; Cobden D; Roze S
    Int J Clin Pract; 2006 Sep; 60(9):1138-45. PubMed ID: 16939559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
    Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
    Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States.
    Ali SN; Dang-Tan T; Valentine WJ; Hansen BB
    Adv Ther; 2020 Feb; 37(2):869-882. PubMed ID: 31925649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of poor glycaemic control in people with newly diagnosed type 2 diabetes in Sweden: A health economic modelling analysis based on nationwide data.
    Hellgren M; Svensson AM; Franzén S; Ericsson Å; Gudbjörnsdottir S; Ekström N; Bertilsson R; Valentine W; Malkin S
    Diabetes Obes Metab; 2021 Jul; 23(7):1604-1613. PubMed ID: 33729661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: A primary care cohort study.
    Whyte MB; Joy M; Hinton W; McGovern A; Hoang U; van Vlymen J; Ferreira F; Mount J; Munro N; de Lusignan S
    Diabetes Obes Metab; 2022 Jul; 24(7):1310-1318. PubMed ID: 35373891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mean HbA
    Forbes A; Murrells T; Mulnier H; Sinclair AJ
    Lancet Diabetes Endocrinol; 2018 Jun; 6(6):476-486. PubMed ID: 29674135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain.
    Mata-Cases M; Casajuana M; Franch-Nadal J; Casellas A; Castell C; Vinagre I; Mauricio D; Bolíbar B
    Eur J Health Econ; 2016 Nov; 17(8):1001-1010. PubMed ID: 26542160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct trajectories of HbA
    Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
    Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International comparison of glycaemic control in people with type 1 diabetes: an update and extension.
    Prigge R; McKnight JA; Wild SH; Haynes A; Jones TW; Davis EA; Rami-Merhar B; Fritsch M; Prchla C; Lavens A; Doggen K; Chao S; Aronson R; Brown R; Ibfelt EH; Svensson J; Young R; Warner JT; Robinson H; Laatikainen T; Rautiainen P; Delemer B; Souchon PF; Diallo AM; Holl RW; Schmid SM; Raile K; Tigas S; Bargiota A; Zografou I; Luk AOY; Chan JCN; Dinneen SF; Buckley CM; Kgosidialwa O; Cherubini V; Gesuita R; Strele I; Pildava S; Veeze H; Aanstoot HJ; Mul D; Jefferies C; Cooper JG; Løvaas KF; Battelino T; Dovc K; Bratina N; Eeg-Olofsson K; Svensson AM; Gudbjornsdottir S; Globa E; Zelinska N
    Diabet Med; 2022 May; 39(5):e14766. PubMed ID: 34890078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
    Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
    Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: A randomised controlled trial.
    Warren R; Carlisle K; Mihala G; Scuffham PA
    J Telemed Telecare; 2018 Oct; 24(9):586-595. PubMed ID: 28814128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.